|
| ID |
DDInter519 |
| Drug Type |
small molecule |
| Molecular Formula |
C16H14F3N3O2S |
| Molecular Weight |
369.367
|
| Description |
Dexlansoprazole is a proton pump inhibitor used to help gastrointestinal ulcers heal, to treat symptoms of gastroesophageal reflux disease (GERD), to eradicate Helicobacter pylori, and to treat hypersecretory conditions such as Zollinger-Ellison Syndrome.
|
| ATC Classification |
A02BC06
|
| IUPAC Name |
2-[(R)-[3-Methyl-4-(2,2,2-Trifluoroethoxy)Pyridin-2-Yl]Methanesulfinyl]-1H-1,3-Benzodiazole |
| InChI |
Inchi=1S/C16H14F3N3O2S/C1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/H2-7H,8-9H2,1H3,(H,21,22)/T25-/M1/S1 |
| InChI Key |
MJIHNNLFOKEZEW-RUZDIDTESA-N |
| Canonical SMILES |
CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|